Travel support request for US participants in BIOT-ESBES meeting (Istanbul, Turkey) from September 23-26, 2012

1246225/Kelly美国国家科学基金会生物技术、生物化学和生物质工程项目的这一奖项将支持13名美国科学家和工程师参加将于2012年9月23日至26日在土耳其伊斯坦布尔举行的第九届欧洲生物化学工程研讨会（http：//events.dechema.de/best2012）。生物工程和生物分子的分离是毕奥，ESBES和ISPPP联合组织的这次活动的主要焦点。研讨会将与第15届欧洲生物技术大会ECB 15同时在同一地点举行，从而有独特的机会参观所有这些大会的完整科学计划。本次峰会的目的是将这些领域的国际科学界聚集在一起，促进沟通，合作和跨学科的思想交流，以分析生命科学行业在应对人类巨大挑战方面的影响。本次会议将为来自工业界和学术界的科学家提供一个独特的平台，以发现新的科学，技术，工艺和应用。会议由一个协调小组组织，该小组由ESBES和William J. Kelly（美国宾夕法尼亚州维拉诺瓦大学）的八名成员组成，他是ACS毕奥执行委员会的现任成员，代表ACS毕奥。一个多样化的ACS毕奥小组委员会的目的是确定美国科学家和工程师邀请作为技术演讲者和主旨发言人在伊斯坦布尔的ECB 15会议。智力MeritThis会议是一个卓越的场所在欧洲讨论在这个多样化和迅速扩大的领域的前沿研究。这次特别的会议为来自这四个不同但重叠的技术领域的美国科学家提供了一个独特的机会，与他们的欧洲同行进行互动。十三位美国与会者将主要主持或在以下领域进行技术演示：生物制药的前沿和创新，生物加工中的纳米技术，干细胞生物工程和细胞治疗，组织工程和系统生物技术和代谢工程。五位美国演讲者被邀请做主题演讲，随后是同一主题领域的简短技术演讲。更广泛的影响本次会议的重点将是欧洲和美国生物技术领域的前沿研究。 会议组织者做出了重大努力，邀请和招募美国演讲者和会议主席来自科学和工程领域代表性不足的团体。来自明尼苏达大学的Claudia Schmidt-Dannert博士是五位美国与会者之一，他们发表了主题演讲。此外，13名美国参与者中有3名来自美国生物制药行业，其余7名是美国学者，代表美国从西海岸到东海岸的大学。由于毕奥和ESBES之间的首次合作，欧洲和美国旗舰科学组织的研究人员在生物技术领域有机会增加交流。 这是加强这两个重要研究团体之间互动的第一步。

1246225/ KellyThis award from the Biotechnology, Biochemical and Biomass Engineering Program of the National Science Foundation will support the participation of thirteen US scientists and engineers who are participating in the 9th European Symposium(http://events.dechema.de/best2012) on Biochemical Engineering to be held in Istanbul, Turkey from September 23-26, 2012. Bioengineering and the separation of biomolecules are the main focus of this jointly organized event of BIOT, ESBES and ISPPP. The symposium will take place at the same time and at the same place as ECB15, the 15th European Congress on Biotechnology, allowing for the unique opportunity to visit the complete scientific program of all these congresses. The idea of this summit is to bring together the international scientific communities in these fields, to foster communication, cooperation, and cross-disciplinary exchange of ideas in analyzing the impact of the life sciences industry in addressing humanity's great challenges. This event will provide a unique platform for scientists both from industry and academia to discover new science, technologies, processes and applications.The meeting is being organized by a coordination group consisting of eight individuals from ESBES and William J. Kelly (Villanova University, PA/USA) who, as a current member of the ACS BIOT executive board, is representing ACS BIOT. A diverse ACS BIOT subcommittee was created for the purposes of identifying US scientists and engineers to invite as technical presenters and keynote speakers at the ECB15 conference in Istanbul.Intellectual MeritThis conference is a pre-eminent venue in Europe for discussing research at the cutting edge of this diverse and rapidly expanding field. This particular meeting provides a unique opportunity for US scientists from not one but these four different but overlapping technical areas involved, to interact with their European counterparts. The thirteen US participants will be primarily chairing or giving technical presentations in the following areas: Frontiers and innovations in biopharmaceuticals, Nanotechnology in bioprocessing, Stem cell bioengineering and cell therapy and tissue engineering and Systems biotechnology and metabolic engineering. Five of the US speakers were invited to give keynote talks to launch sessions that would be followed by shorter technical talks in the same topical area.Broader ImpactsThe focus of this conference will be on research at the cutting-edge of the field of biotechnology in Europe and the US. The conference organizers have made a significant effort to invite and recruit US speakers and session chairs from groups underrepresented in science and engineering. Dr. Claudia Schmidt-Dannert from the University of Minnesota is one of the five US participants giving a keynote presentation. Furthermore, three of the thirteen US participants are from the US biopharmaceuticals industry and the remaining seven are US academics representing universities spanning the US from west to the east coasts. As a result of this first collaboration between BIOT and ESBES, there is the opportunity for increasing exchange between researchers in the flagship scientific organizations in Europe and the US in the areas of biotechnology. This is a first step in increased interaction between these two important research communities.